Kai Xu

Kai Xu

Auto-generated profile, based on publicly available information

Kai Xu

Department of Radiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province 221002, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JWJiangfen Wu
Jiangfen Wu
QXQian Xu
Qian Xu
YSYiqing Shen
Yiqing Shen
WCWeidao Chen
Weidao Chen
KXKai Xu
Kai Xu
XQXian-Rong Qi
Xian-Rong Qi
Background: Deep learning (DL) could predict isocitrate dehydrogenase (IDH) mutation status from MRIs. Yet, previous work focused on CNNs with refined tumor segmentation. To bridge the gap, this study aimed to evaluate the feasibility of developing a Transformer-based network to predict the IDH mutation status free of refined tumor segmentation. Methods: A total of 493 glioma patients were recruited from two independent institutions for model development (TCIA; N = 259) and external test (AHXZ; N = 234). IDH mutation status was predicted directly from T2 images with a Swin Transformer and conventional ResNet. Furthermore, to investigate the necessity of refined tumor segmentation, seven strategies for the model input image were explored: (i) whole tumor slice; (ii–iii) tumor mask and/or not edema; (iv–vii) tumor bounding box of 0.8, 1.0, 1.2, 1.5 times. Performance comparison was made among the networks of different architectures along with different image input strategies, using area under the curve (AUC) and accuracy (ACC). Finally, to further boost the performance, a hybrid model was built by incorporating the images with clinical features. Results: With the seven proposed input strategies, seven Swin Transformer models and seven ResNet models were built, respectively. Based on the seven Swin Transformer models, an averaged AUC of 0.965 (internal test) and 0.842 (external test) were achieved, outperforming 0.922 and 0.805 resulting from the seven ResNet models, respectively. When a bounding box of 1.0 times was used, Swin Transformer (AUC = 0.868, ACC = 80.7%), achieved the best results against the one that used tumor segmentation (Tumor + Edema, AUC = 0.862, ACC = 78.5%). The hybrid model that integrated age and location features into images yielded improved performance (AUC = 0.878, Accuracy = 82.0%) over the model that used images only. Conclusions: Swin Transformer outperforms the CNN-based ResNet in IDH prediction. Using bounding box input images benefits the DL networks in IDH prediction and makes the IDH prediction free of refined glioma segmentation feasible.

1 December 2017 in Medicine
Verified
Journal Article
Open access
QXQian Xu
Qian Xu
QLQi Liu
Qi Liu
HGHaitao Ge
Haitao Ge
XGXinting Ge
Xinting Ge
JWJiangfen Wu
Jiangfen Wu
KXKai Xu
Kai Xu
Gliomas constitute over 90% of primary brain tumors. Accurate identification of glioma recurrence and treatment effects is important, as it can help determine whether to continue with standard adjuvant chemotherapy or to switch to a second-line therapy for recurrence. Our purpose is to compare three dimensional pseudo-continuous arterial spin labeling (3D-pcASL) technique and dynamic susceptibility contrast perfusion magnetic resonance imaging (DSC-MRI) for differentiation tumor recurrence from treatment-related effects in gliomas. Twenty-nine patients with gliomas previously who showed enlarged, contrast-enhancing lesions within the radiation field after surgery and concurrent chemoradiotherapy (CCRT) were assessed with 3D-pcASL and DSC-MRI. These patients were classified into 2 groups, tumor recurrence group (n = 17) and treatment effects group (n = 12), based on pathologic analysis or clinical-radiologic follow-up. The perfusion imaging quality was assessed using a 3-point scale (1 = poor imaging, 2 = moderate imaging, and 3 = good imaging). Comparison for perfusion imaging-quality score between the 2 techniques was performed with Wilcoxon one-sample test. Quantitative analyses were performed between the 2 groups with cerebral blood flow values (ASL-CBF), relative cerebral blood flow values (ASL-rCBF, DSC-rCBF), and relative cerebral blood volume values (DSC-rCBV) using Wilcoxon one-sample test. The intra-class correlation coefficient (ICC) statistics were calculated for testing intrareader variability in regions of interest (ROIs) measurement of all perfusion parameters. The imaging-quality score of 3D-pcASL was higher than that of DSC-MRI (P = .01). The perfusion parameters between tumor recurrence group and treatment effects group had statistically significant differences. There was a significant correlation between ASL-rCBF and DSC-rCBF values (r = 0.803), between ASL-rCBF and DSC-rCBV values (r = 0.763), and between DSC-rCBF and DSC-rCBV (r = 0.907). A receiver operating characteristic (ROC) curve analysis was performed for significant results of perfusion parameters between the 2 groups. Using a cutoff value of 1.110, ASL-rCBF showed the maximum area under the ROC curve (AUC). However, there were no significant differences among different AUCs. The ICC demonstrated excellent agreement for ROIs measurements of ASL-CBF (ICC = 0.9636), dynamic susceptibility contrast- cerebral blood flow (DSC-CBF) (ICC = 0.8508), and dynamic susceptibility contrast-cerebral blood volume (DSC-CBV) (ICC = 0.8543). 3D-pcASL is an alternative perfusion method to DSC-MRI for the differentiation between tumor recurrence and treatment effects in gliomas. 3D-pcASL is noninvasive and shows fewer susceptibility artifacts than DSC-MRI.

17 October 2022 in European Journal of Radiology
Verified
Journal Article
Closed access
QXQian Xu
Qian Xu
QXQian Qian Xu
Qian Qian Xu
NSNian Shi
Nian Shi
LDLi Na Dong
Li Na Dong
HZHong Zhu
Hong Zhu
KXKai Xu
Kai Xu

15 May 2014 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
QXQian Xu
Qian Xu
CJChunjuan Jiang
Chunjuan Jiang
YRYutao Rong
Yutao Rong
CYChun Yang
Chun Yang
YLYing Liu
Ying Liu
KXKai Xu
Kai Xu

1 August 2016 in Medicine
Verified
Journal Article
Open access
QXQian Xu
Qian Xu
CLCailuan Lu
Cailuan Lu
LLLinlin Li
Linlin Li
KXKai Xu
Kai Xu
Clear cell tumor of the lung (CCTL) is a rare and mostly benign pulmonary tumor arising from perivascular epithelioid cells. We reported 2 cases of CCTL in a 24-year-old man with chest pain and a 59-year-old man with dyspnea. Their chest CT images revealed a well-defined, homogeneous nodule located in the peripheral region of lung parenchyma. The solid nodule showed intense heterogenous postcontrast enhancement in the arterial phase and a homogenous appearance in the venous phase. The two patients underwent thoracotomy, and pathological examinations, including immunohistochemical studies revealed that both cases were benign clear cell tumors. Due to the fact that only a few cases about CCTL were reported, clinicopathological aspects and radiological characteristics of this type of tumor are not well established. CCTL is a rare and benign primary tumor and majorly occurs in middle-aged and elder people. The finding of a small vessel extending along and partially wrapping up one side of the mass in the CT-enhanced images might be a helpful feature to differentiate CCTL from other lung neoplasms.

21 April 2020 in Research Square
Verified
Preprint
Open access
PDF file
QXQian Xu
Qian Xu
LSLin Shi
Lin Shi
MLMengshuang Li
Mengshuang Li
LDLina Dong
Lina Dong
LCLulu Cai
Lulu Cai
KXKai Xu
Kai Xu
Purpose: To find the pulmonary CT imaging characteristics in patients recovering from coronavirus disease 2019 (COVID-19).Method: Twenty patients with confirmed COVID-19 were enrolled. We analyzed the changes of four pulmonary CT imaging manifestations (ground glass opacity, consolidation, crazy paving sign and cord/band sign) in patients during hospitalization. The disease course was divided into four stages: early stage (0-4 days), progressive stage (5-8 days), peak stage (9-13 days) and absorption stage (≥14 days).Results: There were 12 male and 8 female with an average age of 45±16 years. In the first three stages, GGO was the most common sign on CT imaging. Then, the proportion of GGO decreased in the absorption stage compared with the first three stages (P<0.05). The proportion of crazy paving sign peaked in the progressive stage and then declined, with statistical difference between the progressive stage and the absorption stage (P<0.05). Cord/band sign was increasing from the early stage to the absorption stage, and statistical differences were found between the early stage and the peak stage (P<0.05), as well as the absorption stage and the first three stages (P<0.05). No statistical differences of consolidation proportion were found among the four stages.Conclusions: CT imaging showed different characteristics during the four stages. The proportion of cord/band sign significantly increased in the third stage, which might be an indicator of COVID-19 improvement.